AFFY (AFFY) Stock Price & Analysis
AFFY (AFFY) rose 0.00% to USD 0 as of June 10, 2026 at 04:07 UTC, according to Nexqual real-time market data.
AFFY last closed at USD 0; the session ranged USD 0–0 on volume of 6,000 shares. Market capitalization is $37,490, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 04:07 UTC.
Key Statistics (as of June 10, 2026 at 04:07 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 6,000 shares |
| Market Cap | $37,490 |
| Exchange | PNK |
Technical Analysis (AFFY)
Nexqual's technical model rates AFFY "NEUTRAL" based on 2 bullish and 3 bearish signals across 124 daily candles, as of June 10, 2026 at 04:07 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 41.35 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (AFFY)
Wall Street analysts rate AFFY "None", per Nexqual as of June 10, 2026 at 04:07 UTC.
| Consensus Rating | None |
|---|
Earnings (AFFY)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2013-03-31 | USD -0.9 vs est -0.66 ▼ miss |
| 2012-12-31 | USD -0.63 vs est -0.61 ▼ miss |
| 2012-09-30 | USD -0.68 vs est -0.71 ▲ beat |
| 2012-06-30 | USD -0.89 vs est -0.67 ▼ miss |
Source: Nexqual, June 10, 2026 at 04:07 UTC.
Financials & Fundamentals (AFFY)
| Total Revenue | $42,000 |
|---|---|
| Revenue Growth (YoY) | -92.00% |
| Gross Margin | +497.62% |
| Operating Margin | -2438.09% |
| Profit Margin | +7300.00% |
| ROE | +111.59% |
| Current Ratio | 20.81 |
| Total Cash | $3.40M |
| Total Debt | $0 |
| Free Cash Flow | $-41.41M |
Source: Nexqual, June 10, 2026 at 04:07 UTC.
Financial Health Score (AFFY)
Nexqual rates AFFY's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 04:07 UTC.
| Growth | Strong — Revenue +98% YoY (annual) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $3M cash, no debt |
| Cash Flow | Weak — FCF negative: -$41M, burning cash |
| Efficiency | Strong — ROE 112%, ROA -228.9% |
Ownership (AFFY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 37.49M |
| Short % of Float | +49.35% |
Source: Nexqual, June 10, 2026 at 04:07 UTC.
Leadership (AFFY)
AFFY is led by Jonathan M. Couchman (age 55), CEO, President & Director, per Nexqual as of June 10, 2026 at 04:07 UTC.
| CEO, President & Director | Jonathan M. Couchman (age 55) |
|---|---|
| CFO & Secretary | Mark G. Thompson (age 63) |
| Vice President of Intellectual Property & Legal Affairs | Tracy J. Dunn (age 62) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ACUR | ACURA PHARMACEUTICALS INC | USD 0 | ▲ 0% |
| PARD | PONIARD PHARMACEUT | USD 0 | ▲ 0% |
| IMUC | EOM Pharmaceutical Holdings Inc | USD 0.25 | ▲ 17.92% |
| ANTH | ANTHERA PHARMACEUTICALS INC | USD 0 | ▲ 0% |
| MITI | MITESCO, INC. | USD 0.08 | ▼ 6.25% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 04:07 UTC. This page is informational and not investment advice.